{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:38:58Z","timestamp":1792471138775,"version":"4.5.0"},"reference-count":21,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"the Youth Cultivation Project of Xi\u2019an Health Committee","award":["2025qn04"],"award-info":[{"award-number":["2025qn04"]}]},{"name":"Xi\u2019an People\u2019s Hospital"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Urology"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The optimal management of 2\u20133\u2009cm renal stones remains challenging because effective stone clearance must be balanced against perioperative morbidity. Mini-percutaneous nephrolithotomy (mPCNL) provides high stone-free rates (SFR) but is associated with greater procedural burden, whereas flexible ureteroscopic lithotripsy (fURL) is less invasive but may be limited by fragment clearance efficiency. A flexible vacuum-assisted ureteral access sheath (FV-UAS) has recently been introduced to facilitate fragment evacuation and improve intrarenal drainage during fURL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To compare the efficacy and safety of FV-UAS\u2013assisted fURL, conventional ureteral access sheath\u2013assisted flexible ureteroscopic lithotripsy (UAS\u2013assisted fURL), and mPCNL for the treatment of 2\u20133\u2009cm renal stones, and to provide evidence for surgical decision-making in this clinical setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>This was a retrospective single-center comparative study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This retrospective study included 156 patients with 2\u20133\u2009cm renal stones who underwent FV-UAS\u2013assisted fURL (FV-UAS group,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200950), UAS\u2013assisted fURL (UAS group,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200954), or mPCNL (mPCNL group,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200952) at Xi\u2019an People\u2019s Hospital between June 2022 and December 2024. Perioperative outcomes were compared, including operative time, postoperative hemoglobin decrease, postoperative pain assessed by the visual analogue scale (VAS), postoperative length of hospital stay, total hospitalization costs, and postoperative adverse events, including fever, renal colic, urinary tract infection, and steinstrasse. SFR was assessed on postoperative day 3 and at 1\u2009month postoperatively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Operative time differed significantly among the three groups (FV-UAS 77.56\u2009\u00b1\u200915.04\u2009min vs mPCNL 67.60\u2009\u00b1\u200910.44\u2009min vs UAS 85.04\u2009\u00b1\u200915.78\u2009min;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Postoperative hemoglobin decrease was significantly lower in the FV-UAS and UAS groups than in the mPCNL group (3.50\u2009\u00b1\u20092.40\u2009g\/L and 4.01\u2009\u00b1\u20092.14\u2009g\/L vs 13.86\u2009\u00b1\u20093.21\u2009g\/L;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The postoperative length of stay was shorter in the FV-UAS group than in the UAS group and markedly shorter than in the mPCNL group (3.04\u2009\u00b1\u20090.73\u2009d vs 3.52\u2009\u00b1\u20090.72\u2009d vs 6.04\u2009\u00b1\u20090.86\u2009d;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Postoperative VAS scores were lower in the FV-UAS and UAS groups than in the mPCNL group (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.05), with no significant difference between the two fURL groups. Regarding total hospitalization costs, the mPCNL group had the lowest costs, and the FV-UAS group had lower costs than the UAS group (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.05). The overall adverse event rates were comparable among groups. Steinstrasse occurred in three cases, all in the UAS group. On postoperative day 3, SFRs were 94.0% (FV-UAS), 75.9% (UAS), and 80.8% (mPCNL), with the FV-UAS group higher than the UAS group (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.05). At 1\u2009month, SFRs were 96.0% (FV-UAS), 81.5% (UAS), and 96.2% (mPCNL), with both the FV-UAS and mPCNL groups higher than the UAS group (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>For 2\u20133\u2009cm renal stones, FV-UAS\u2013assisted fURL was associated with less hemoglobin decrease, lower postoperative pain, and shorter hospital stay than mPCNL, and showed advantages over UAS\u2013assisted fURL in operative time and hospitalization costs, while achieving a 1-month SFR comparable to mPCNL. FV-UAS\u2013assisted fURL may represent a safe and effective minimally invasive alternative for 2\u20133\u2009cm renal stones.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562872261452324","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:00:31Z","timestamp":1780642831000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of the efficacy and safety of flexible vacuum-assisted ureteral access sheath\u2013assisted flexible ureteroscopic lithotripsy, conventional ureteral access sheath\u2013assisted flexible ureteroscopic lithotripsy, and mini-percutaneous nephrolithotomy for 2\u20133\u2009cm renal stones"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3563-7294","authenticated-orcid":false,"given":"Hao","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Urology, Xi\u2019an People\u2019s Hospital (Xi\u2019an Fourth Hospital), School of Life Sciences and Medicine, Northwest University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Urology, Xi\u2019an People\u2019s Hospital (Xi\u2019an Fourth Hospital), School of Life Sciences and Medicine, Northwest University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Urology, Xi\u2019an People\u2019s Hospital (Xi\u2019an Fourth Hospital), School of Life Sciences and Medicine, Northwest University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology, Xi\u2019an People\u2019s Hospital (Xi\u2019an Fourth Hospital), School of Life Sciences and Medicine, Northwest University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Urology, Xi\u2019an People\u2019s Hospital (Xi\u2019an Fourth Hospital), School of Life Sciences and Medicine, Northwest University, Xi\u2019an 710199, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-017-2008-6"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13828"},{"key":"e_1_3_4_4_2","article-title":"Minimally invasive percutaneous nephrolithotomy (PCNL): techniques and outcomes","volume":"46","author":"Kallidonis P","year":"2020","unstructured":"Kallidonis P, Tsaturyan A, Lattarulo M, et al. Minimally invasive percutaneous nephrolithotomy (PCNL): techniques and outcomes. Turk J Urol 2020; 46: S58\u2013S63.","journal-title":"Turk J Urol"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-017-0200-z"},{"key":"e_1_3_4_6_2","first-page":"63","article-title":"Disposable versus reusable ureteroscopes: a prospective multicenter randomized comparison","volume":"13","author":"Bozzini G","year":"2021","unstructured":"Bozzini G, Filippi B, Alriyalat S, et al. Disposable versus reusable ureteroscopes: a prospective multicenter randomized comparison. Res Rep Urol 2021; 13: 63\u201371.","journal-title":"Res Rep Urol"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-023-01459-x"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-015-0768-2"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-021-03656-y"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2378-4"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-024-01539-6"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-024-01576-1"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-024-05016-y"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-024-03995-w"},{"key":"e_1_3_4_16_2","first-page":"603","article-title":"Does success in percutaneous nephrolithotomy depend only on stone size? analysis of the predictive capacity for success and complications of the current nephrolithometry scoring systems and their relationship with the stone surface","volume":"48","author":"Fern\u00e1ndez Baltar C","year":"2024","unstructured":"Fern\u00e1ndez Baltar C, Gude Sampedro F, P\u00e9rez Fentes D. Does success in percutaneous nephrolithotomy depend only on stone size? analysis of the predictive capacity for success and complications of the current nephrolithometry scoring systems and their relationship with the stone surface. Actas Urol Esp (Engl Ed) 2024; 48: 603\u2013610.","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2023.06.009"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-023-01478-8"},{"key":"e_1_3_4_19_2","first-page":"49","article-title":"Efficacy and safety of fURS in stones larger than 20 mm: is it still the threshold?","volume":"73","author":"Karag\u00f6z MA","year":"2020","unstructured":"Karag\u00f6z MA, Erihan IB, Doluo\u011flu \u00d6G, et al. Efficacy and safety of fURS in stones larger than 20 mm: is it still the threshold? Cent European J Urol 2020; 73: 49\u201354.","journal-title":"Cent European J Urol"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-023-01341-3"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001836"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2455-8"}],"container-title":["Therapeutic Advances in Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562872261452324","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562872261452324","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562872261452324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:18:35Z","timestamp":1780820315000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562872261452324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":21,"alternative-id":["10.1177\/17562872261452324"],"URL":"https:\/\/doi.org\/10.1177\/17562872261452324","relation":{},"ISSN":["1756-2872","1756-2880"],"issn-type":[{"value":"1756-2872","type":"print"},{"value":"1756-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"article-number":"17562872261452324"}}